These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24584936)

  • 21. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
    Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan-cardanol fluorescent nanoparticles inhibit α-synuclein aggregation and disrupt amyloid fibrils.
    Sunny LP; Srikanth P; Sunitha AK; Tembulkar N; Abraham JN
    J Pept Sci; 2022 Apr; 28(4):e3374. PubMed ID: 34651357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
    Lam HT; Graber MC; Gentry KA; Bieschke J
    Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
    Ardah MT; Ghanem SS; Abdulla SA; Lv G; Emara MM; Paleologou KE; Vaikath NN; Lu JH; Li M; Vekrellis K; Eliezer D; El-Agnaf OMA
    BMC Complement Med Ther; 2020 Mar; 20(1):73. PubMed ID: 32143619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
    Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
    Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
    J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
    Bickle L; Hopwood JJ; Karageorgos L
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.
    Paciotti S; Bellomo G; Gatticchi L; Parnetti L
    Front Neurol; 2018; 9():415. PubMed ID: 29928254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the prion protein in the internalization of α-synuclein amyloids.
    De Cecco E; Legname G
    Prion; 2018 Jan; 12(1):23-27. PubMed ID: 29308725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells.
    Ugalde CL; Annesley SJ; Gordon SE; Mroczek K; Perugini MA; Lawson VA; Fisher PR; Finkelstein DI; Hill AF
    Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
    Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
    Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
    Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L
    PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein Dimers as Potent Inhibitors of Fibrillization.
    Kyriukha YA; Afitska K; Kurochka AS; Sachan S; Galkin M; Yushchenko DA; Shvadchak VV
    J Med Chem; 2019 Nov; 62(22):10342-10351. PubMed ID: 31625739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
    Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Phycocyanin from Spirulina Inhibits α-Synuclein and Amyloid-β Fibril Formation but Not Amorphous Aggregation.
    Liu Y; Jovcevski B; Pukala TL
    J Nat Prod; 2019 Jan; 82(1):66-73. PubMed ID: 30620188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.
    Cohlberg JA; Li J; Uversky VN; Fink AL
    Biochemistry; 2002 Feb; 41(5):1502-11. PubMed ID: 11814343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein.
    Medvedeva M; Barinova K; Melnikova A; Semenyuk P; Kolmogorov V; Gorelkin P; Erofeev A; Muronetz V
    Biochimie; 2020 Mar; 170():128-139. PubMed ID: 31945397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.